Today

Agents

Chat

Arena

Discover

More

App

Codexis appoints David Butler to strategic advisory board - CDXS News | Rallies

Codexis appoints David Butler to strategic advisory board

CDXS•2026-08-03

Codexis adds David Butler to strategic advisory board

Codexis named David Butler to its Strategic Advisory Board to advise on enzymatic manufacturing for siRNA and other oligonucleotide therapeutics.
Butler most recently served as CTO at Hongene Biotech from 2023 to 2026.
He previously led chemistry groups at Wave Life Sciences, Korro Bio, and Alltrna.
Carole Cobb stepped down from the Strategic Advisory Board.

Related News

Boeing <BA.N>: BNP Paribas raises to outperform rating; raises target price to $300

BA•2026-08-03

Ryan Specialty Holdings Inc <RYAN.N>: UBS Raises Target Price to $55 From $50

RYAN•2026-08-03

US manufacturing activity jumps to more than four-year high in July

•

2026-08-03

Nasdaq trade halt continues <PLTS.O> reason not available at 09:44 AM

PLTS•2026-08-03

HomeTrust Bancshares director Laura C. Kendall disposes of 10,000 common shares for $511,348

HTBI•2026-08-03